Crossref

1. The food plant Silybum marianum (L.) Gaertn.: Phytochemistry, Ethnopharmacology and clinical evidence

- Ilias Marmouzi

- Abdelhakim Bouyahya

- Shahira M. Ezzat

- Meryem El Jemli

- Mourad Kharbach

2. How to optimize HCV therapy in genotype 2 patients

- Eleonora Grassi

- Alessio Aghemo

3. Antiviral Activities of Silymarin and Derivatives

- Ching-Hsuan Liu

- Alagie Jassey

- Hsin-Ya Hsu

- Liang-Tzung Lin

4. Are alterations needed in Silybum marianum (Silymarin) administration practices? A novel outlook and meta-analysis on randomized trials targeting liver injury

- Kasra Shahsavari

- Shireen Shams Ardekani

- Mohammad Reza Shams Ardekani

- Majid Mokaber Esfahani

- Hossein Kazemizadeh

- Tannaz Jamialahmadi

- Mehrdad Iranshahi

- Mahnaz Khanavi

- Maede Hasanpour

5. Silibinin: An old drug in the high tech era of liver transplantation

- Peter Ferenci

- Sandra Beinhardt

6. Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection

- Mirjam Zeisel

- Emilie Crouchet

- Thomas Baumert

- Catherine Schuster

7. A Comprehensive Review on the Antibacterial, Antifungal, Antiviral, and Antiparasitic Potential of Silybin

- José Lima Pereira-Filho

- Amanda Graziela Gonçalves Mendes

- Carmem Duarte Lima Campos

- Israel Viegas Moreira

- Cinara Regina Aragão Vieira Monteiro

- Suzany Hellen da Silva Soczek

- Elizabeth Soares Fernandes

- Rafael Cardoso Carvalho

- Valério Monteiro-Neto

8. Analysis of hepatitis C virus resistance to silibinin in vitro and in vivo points to a novel mechanism involving nonstructural protein 4B

- Katharina Esser-Nobis

- Inés Romero-Brey

- Tom M. Ganten

- Jérôme Gouttenoire

- Christian Harak

- Rahel Klein

- Peter Schemmer

- Marco Binder

- Paul Schnitzler

- Darius Moradpour

- Ralf Bartenschlager

- Stephen J. Polyak

- Wolfgang Stremmel

- François Penin

- Christoph Eisenbach

- Volker Lohmann

9. Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection

- Stephen J. Polyak

- Peter Ferenci

- Jean-Michel Pawlotsky

10. Antiviral activity and safety profile of silibinin in HCV patients with advanced fibrosis after liver transplantation: a randomized clinical trial

- Maria Rendina

- Massimo D'Amato

- Antonino Castellaneta

- Nicola Maurizio Castellaneta

- Nadia Brambilla

- Giampaolo Giacovelli

- Lucio Rovati

- Salvatore Fabio Rizzi

- Marianna Zappimbulso

- Roberto Spyridon Bringiotti

- Alfredo Di Leo

11. Sustained virological response with intravenous silibinin: individualized IFN‐free therapy via real‐time modelling of HCV kinetics

- Harel Dahari

- Shimon Shteingart

- Inna Gafanovich

- Scott J. Cotler

- Massimo D'Amato

- Ralf T. Pohl

- Gali Weiss

- Yaakov J. Ashkenazi

- Thomas Tichler

- Eran Goldin

- Yoav Lurie

12. Hepatitis C virus infection and tight junction proteins: The ties that bind

- Laurent Mailly

- Thomas F. Baumert

13. Host-targeting therapies for hepatitis C virus infection: current developments and future applications

- Emilie Crouchet

- Florian Wrensch

- Catherine Schuster

- Mirjam B. Zeisel

- Thomas F. Baumert